Literature DB >> 25244575

Prevalence of Airflow Obstruction in U.S. Adults Aged 40-79 Years: NHANES Data 1988-1994 and 2007-2010.

Brent Doney1, Eva Hnizdo, Charles F Dillon, Ryne Paulose-Ram, Timothy Tilert, Michael Wolz, Lu-Ann Beeckman-Wagner.   

Abstract

BACKGROUND: The study evaluated the change in the prevalence of airflow obstruction in the U.S. population 40-79 years of age from years 1988-1994 to 2007-2010.
METHODS: Spirometry data from two representative samples of the U.S. population, the National Health and Nutrition Examination Surveys (NHANES) conducted in 1988-1994 and 2007-2010, were used. The American Thoracic Society/European Respiratory Society (ATS/ERS) criteria were used to define airflow obstruction.
RESULTS: Based on ATS/ERS criteria, the overall age-adjusted prevalence of airflow obstruction among adults aged 40-79 years decreased from 16.6% to 14.5% (p < 0.05). Significant decreases were observed for the older age category 60-69 years (20.2% vs. 15.4%; p < 0.01), for males (19.0% vs. 15.4%; p < 0.01), and for Mexican American adults (12.7% vs. 8.4%; p < 0.001). The prevalence of moderate and more severe airflow obstruction decreased also (6.4% vs. 4.4%; p < 0.01). Based on ATS/ERS criteria, during 2007-2010, an estimated 18.3 million U.S. adults 40-79 years had airflow obstruction, 5.6 million had moderate or severe airflow obstruction and 1.4 million had severe airflow obstruction.
CONCLUSIONS: The overall age-adjusted prevalence of airflow obstruction among U.S. adults aged 40-79 years decreased from 1988-1994 to 2007-2010, especially among older adults, Mexican Americans, and males.

Entities:  

Keywords:  NHANES; airflow obstruction; chronic obstructive pulmonary disease; spirometry

Mesh:

Year:  2015        PMID: 25244575      PMCID: PMC5567729          DOI: 10.3109/15412555.2014.948998

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  31 in total

1.  Age adjustment using the 2000 projected U.S. population.

Authors:  R J Klein; C A Schoenborn
Journal:  Healthy People 2010 Stat Notes       Date:  2001-01

2.  Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1.

Authors:  P J Sterk
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

3.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

4.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

Review 5.  Health effects of fine particulate air pollution: lines that connect.

Authors:  C Arden Pope; Douglas W Dockery
Journal:  J Air Waste Manag Assoc       Date:  2006-06       Impact factor: 2.235

6.  Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study.

Authors:  Francine Laden; Joel Schwartz; Frank E Speizer; Douglas W Dockery
Journal:  Am J Respir Crit Care Med       Date:  2006-01-19       Impact factor: 21.405

7.  Case definitions for chronic obstructive pulmonary disease.

Authors:  Eva Hnizdo; Henry W Glindmeyer; Edward L Petsonk; Paul Enright; A Sonia Buist
Journal:  COPD       Date:  2006-06       Impact factor: 2.409

8.  Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Authors:  A Johannessen; E R Omenaas; P S Bakke; A Gulsvik
Journal:  Thorax       Date:  2005-08-05       Impact factor: 9.139

Review 9.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 10.  The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.

Authors:  Don D Sin; LieLing Wu; S F Paul Man
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

View more
  12 in total

1.  Telehealth Pulmonary Rehabilitation for Patients With Severe Chronic Obstructive Pulmonary Disease.

Authors:  Mon S Bryant; Venkata D Bandi; Christina K Nguyen; Charlie Lan; Helene K Henson; Amir Sharafkhaneh
Journal:  Fed Pract       Date:  2019-09

2.  Prevalence of airflow obstruction among ever-employed US adults aged 18-79 years by longest held occupation group: National Health and Nutrition Examination Survey 2007-2008.

Authors:  Laura Kurth; Brent Doney; Cara Halldin
Journal:  Occup Environ Med       Date:  2016-05-05       Impact factor: 4.402

3.  Airflow obstruction among ever-employed U.S. adults aged 18-79 years by industry and occupation: NHANES 2007-2008 to 2011-2012.

Authors:  Laura Kurth; Brent Doney; Cara Halldin; Janet Hale; Steven M Frenk
Journal:  Am J Ind Med       Date:  2018-12-05       Impact factor: 2.214

4.  Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors.

Authors:  Cara N Halldin; Brent C Doney; Eva Hnizdo
Journal:  Chron Respir Dis       Date:  2014-12-24       Impact factor: 2.444

5.  Sleep Apnea and Obstructive Airway Disease in Older Men: Outcomes of Sleep Disorders in Older Men Study.

Authors:  Ying Y Zhao; Terri Blackwell; Kristine E Ensrud; Katie L Stone; Theodore A Omachi; Susan Redline
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

6.  Styrene-associated health outcomes at a windblade manufacturing plant.

Authors:  Anna-Binney McCague; Jean M Cox-Ganser; Joshua M Harney; K Udeni Alwis; Benjamin C Blount; Kristin J Cummings; Nicole Edwards; Kathleen Kreiss
Journal:  Am J Ind Med       Date:  2015-08-25       Impact factor: 2.214

7.  Effect of Emphysema Severity on the Apnea-Hypopnea Index in Smokers with Obstructive Sleep Apnea.

Authors:  Samuel L Krachman; Rachna Tiwari; Maria Elena Vega; Daohai Yu; Xavier Soler; Fredric Jaffe; Victor Kim; Irene Swift; Gilbert E D'Alonzo; Gerard J Criner
Journal:  Ann Am Thorac Soc       Date:  2016-07

8.  Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 2007-2010.

Authors:  Laura Kurth; Eva Hnizdo
Journal:  Multidiscip Respir Med       Date:  2015-02-28

9.  COPD in a Population-Based Sample of Never-Smokers: Interactions among Sex, Gender, and Race.

Authors:  Esme Fuller-Thomson; Rachel S Chisholm; Sarah Brennenstuhl
Journal:  Int J Chronic Dis       Date:  2016-12-07

10.  Multimorbidity of four cardiometabolic and chronic pulmonary disease groups: prevalence and attributable fraction in US adults, 2007-2012.

Authors:  Lisa R Staimez; Melissa Y Wei; Min Kim; K M Venkat Narayan; Sharon H Saydah
Journal:  J Comorb       Date:  2017-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.